Evelyn J Kim1, Wolfgang Hladik1, Joseph Barker1, George Lubwama2, Samuel Sendagala3, John M Ssenkusu3, Alex Opio4, David Serwadda2. 1. Division of Global HIV/AIDS, Center for Global Health, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA. 2. School of Public Health, Makerere University, Kampala, Uganda. 3. Division of Global HIV/AIDS, Center for Global Health, Centers for Disease Control and Prevention (CDC), Entebbe, Uganda. 4. Ministry of Health, Kampala, Uganda.
Abstract
OBJECTIVES: Few studies have been conducted in Africa to assess prevalence of sexually transmitted infections (STIs) and risk factors among men who have sex with men (MSM). We report findings from the first behavioural survey to include STI testing among MSM in Kampala, Uganda. METHODS: Respondent-driven sampling (RDS) was used to recruit MSM for a biobehavioural survey. Eligible participants were men who reported anal sex with another man in the previous 3 months, were 18 years or older, and resided in Kampala. Information was collected on demographics, sexual behaviour, alcohol and drug use, and STI symptoms. Blood, urine and rectal specimens were tested for syphilis, HIV, rectal and urethral gonorrhoea, and chlamydia. Analyses weighted for RDS were conducted to assess associations with STI diagnosis. RESULTS: A total of 295 MSM participated in the survey. Almost half (weighted percentage: 47.3%) reported STI symptoms in the last 6 months and 12.9% tested HIV-positive. Prevalence of non-HIV STI was 13.5%; syphilis prevalence was 9.0%. Adjusting for age and education, STI was associated with HIV (adjusted OR (AOR)=3.46, 95% CI 1.03 to 11.64), alcohol use before sex (AOR=4.99, 95% CI 1.86 to 13.38) and having sold sex in the last 3 months (AOR=3.17, 95% CI 1.25 to 8.07), and inversely associated with having anonymous sex partners (AOR=0.20, 95% CI 0.07 to 0.61). CONCLUSIONS: We observed high levels of self-reported STI symptoms and STI prevalence associated with alcohol use and HIV among MSM in Kampala. Public health interventions supporting MSM are needed to address STI risk and facilitate access to diagnosis and treatment services. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
OBJECTIVES: Few studies have been conducted in Africa to assess prevalence of sexually transmitted infections (STIs) and risk factors among men who have sex with men (MSM). We report findings from the first behavioural survey to include STI testing among MSM in Kampala, Uganda. METHODS: Respondent-driven sampling (RDS) was used to recruit MSM for a biobehavioural survey. Eligible participants were men who reported anal sex with another man in the previous 3 months, were 18 years or older, and resided in Kampala. Information was collected on demographics, sexual behaviour, alcohol and drug use, and STI symptoms. Blood, urine and rectal specimens were tested for syphilis, HIV, rectal and urethral gonorrhoea, and chlamydia. Analyses weighted for RDS were conducted to assess associations with STI diagnosis. RESULTS: A total of 295 MSM participated in the survey. Almost half (weighted percentage: 47.3%) reported STI symptoms in the last 6 months and 12.9% tested HIV-positive. Prevalence of non-HIV STI was 13.5%; syphilis prevalence was 9.0%. Adjusting for age and education, STI was associated with HIV (adjusted OR (AOR)=3.46, 95% CI 1.03 to 11.64), alcohol use before sex (AOR=4.99, 95% CI 1.86 to 13.38) and having sold sex in the last 3 months (AOR=3.17, 95% CI 1.25 to 8.07), and inversely associated with having anonymous sex partners (AOR=0.20, 95% CI 0.07 to 0.61). CONCLUSIONS: We observed high levels of self-reported STI symptoms and STI prevalence associated with alcohol use and HIV among MSM in Kampala. Public health interventions supporting MSM are needed to address STI risk and facilitate access to diagnosis and treatment services. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Authors: Abdoulaye S Wade; Joseph Larmarange; Abdou K Diop; Oulimata Diop; Khady Gueye; Adama Marra; Amsata Sene; Catherine Enel; Pape Niang Diallo; Ndeye Coumba Toure Kane; Souleymane Mboup; Annabel Desgrées-du-Lou Journal: AIDS Care Date: 2010-04
Authors: Lisa G Johnston; Abigail Holman; Mohammed Dahoma; Leigh Ann Miller; Evelyn Kim; Mahmoud Mussa; Asha A Othman; Andrea Kim; Carl Kendall; Keith Sabin Journal: Int J Drug Policy Date: 2010-07-16
Authors: Phoebe Kajubi; Moses R Kamya; H Fisher Raymond; Sanny Chen; George W Rutherford; Jeffrey S Mandel; Willi McFarland Journal: AIDS Behav Date: 2007-10-30
Authors: Judith Branger; Jan T M van der Meer; Ruud J van Ketel; Suzanne Jurriaans; Jan M Prins Journal: Sex Transm Dis Date: 2009-02 Impact factor: 2.830
Authors: Mary C Cambou; Amaya G Perez-Brumer; Eddy R Segura; H Javier Salvatierra; Javier R Lama; Jorge Sanchez; Jesse L Clark Journal: PLoS One Date: 2014-07-16 Impact factor: 3.240
Authors: Theodorus G M Sandfort; Justin R Knox; Carolina Alcala; Nabila El-Bassel; Irene Kuo; Laramie R Smith Journal: J Acquir Immune Defic Syndr Date: 2017-10-01 Impact factor: 3.731
Authors: Laura A S Quilter; Eve Obondi; Colin Kunzweiler; Duncan Okall; Robert C Bailey; Gaston Djomand; Boaz Otieno-Nyunya; Fredrick Otieno; Susan M Graham Journal: Sex Transm Infect Date: 2018-09-21 Impact factor: 3.519
Authors: Trevor A Crowell; Babajide Keshinro; Stefan D Baral; Sheree R Schwartz; Shauna Stahlman; Rebecca G Nowak; Sylvia Adebajo; William A Blattner; Manhattan E Charurat; Julie A Ake Journal: J Int AIDS Soc Date: 2017-04-20 Impact factor: 5.396